Patent application number | Description | Published |
20090162426 | Use of a Compound with RANKL Activity - The present invention relates to the use of a compound with receptor activator of nuclear factor-kB ligand (RANKL) activity for the manufacture of a topical pharmaceutical formulation for the modulation of local or systemic Treg numbers and the treatment or the prevention of skin-associated or systemic diseases. | 06-25-2009 |
20130030007 | Obesity Small Molecules - The present invention relates to new therapies to treat obesity and related diseases, as well as for reducing triglyceride levels and body weight. | 01-31-2013 |
20130216550 | BREAST CANCER THERAPEUTICS - The present invention relates to a method of treating or preventing cancer in a subject comprising administering a therapeutically effective amount of a RANKL inhibitor to said patient. | 08-22-2013 |
20130252924 | Compounds and Methods for Treating Pain - The present invention relates to new therapies to treat pain and related diseases, as well as pharmaceutical compounds for use in said therapies. | 09-26-2013 |
20130316374 | BREAST CANCER DIAGNOSTICS - The present invention relates to methods and means for detecting cancer or of predicting a patient developing cancer or of determining the rate of progression of cancer in a patient suffering from cancer, comprising determining RANKL activity and/or the amount of OPG in a sample of said patient. | 11-28-2013 |
20140302023 | USE OF RANK/RANKL ANTAGONISTS FOR TREATING NEUROMUSCULAR DISORDERS, GENETIC MYOPATHIES AND/OR NON GENETIC MYOPATHIES AND/OR FOR REGULATING SKELETAL AND CARDIAC MUSCLE DISUSE, DISEASES AND AGING - A pharmaceutical composition includes one or more RANK/RANKL antagonists and a pharmaceutically acceptable carrier. The composition can be used for treating neuromuscular disorders, non-genetic myopathies, or genetic myopathies; maintaining and/or preserving the excitation:contraction:relaxation coupling; reducing loss of muscle strength associated with neuromuscular disorders, non-genetic myopathies or genetic myopathies; reducing the loss of muscular strength associated with skeletal or cardiac muscle disuse, diseases and aging; or regulating skeletal or cardiac muscle disuse, diseases and/or aging in a patient in need thereof. Methods are used to identify candidate compounds. | 10-09-2014 |
20140342369 | HAPLOID CELLS - The present invention relates to the generation of stable haploid cell cultures, uses of said cells in forward and reverse genetics, especially the identification of target genes associated with a modified phenotype and in particular identifying genetic targets associated with toxin resistance, especially ricin toxicity resistance, and therapeutic uses of target compounds. | 11-20-2014 |
20140349969 | COMPOUNDS AND METHODS FOR TREATING PAIN - The present invention relates to new therapies to treat pain and related diseases, as well as pharmaceutical compounds for use in said therapies. | 11-27-2014 |
Patent application number | Description | Published |
20080234167 | Colour Protection Washing Product - Washing products which comprise a dye transfer inhibitor selected from the group consisting of triazine derivatives of the general formulae I, II, III and combinations thereof: | 09-25-2008 |
20080301883 | BOOSTING CLEANING POWER OF DETERGENTS BY MEANS OF A POLYMER - Textiles are washed by a method comprising contacting the textile with a cleaning composition comprising a copolymer comprising styrene, methacrylic acid, hydroxyethyl methacrylate, and methyl acrylate. | 12-11-2008 |
20080313819 | GRAYING-INHIBITING LIQUID WASHING COMPOSITION - An aqueous liquid laundry detergent containing methylcarboxymethyl cellulose having a degree of methylation in the range from 0.01 to 0.3, surfactant, and at least one typical ingredient of laundry detergents. The detergent inhibits graying of textile fabrics during the washing of the fabrics. | 12-25-2008 |
20090069210 | COLOUR-PROTECTING LAUNDRY DETERGENT COMPOSITION - Detergent compositions comprising a color transfer inhibitor and optionally surfactant(s), the color transfer inhibitor comprising one or more compounds selected from the group consisting of triazine derivatives corresponding to general formulae I and II: | 03-12-2009 |
20090137444 | Laundry Detergent Acting on Cotton and Comprising Soil-Releasing Cellulose Derivative - A method of improving the cleaning performance of laundry detergents when washing textiles that are made of or contain cotton by contacting the textile with a cellulose derivative that contains, on average, 0.4 to 2.7 alkyl groups and 0.001 to 0.3 carboxyalkyl groups per anhydroglycose monomer unit. | 05-28-2009 |
20090143271 | Colour-protecting laundry detergent - Laundry detergents containing a hyperbranched polyesteramide to inhibit transfer of dye during the washing of colored textiles. Also, methods of washing dyed textiles in surfactant-containing aqueous solutions also containing a hyperbranched polyesteramide. | 06-04-2009 |
20120196785 | TRIAZINE DERIVATIVE DYE TRANSFER INHIBITORS, WASHING PRODUCTS CONTAINING THE SAME AND USES THEREFOR - Washing products comprising a dye transfer inhibitor selected from triazine derivatives of the general formulae T(NH—Ar(SO | 08-02-2012 |